BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26857496)

  • 1. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
    Xie C; Ciric B; Yu S; Zhang GX; Rostami A
    J Neuroimmunol; 2016 Feb; 291():59-69. PubMed ID: 26857496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
    J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system.
    Zhang GX; Gran B; Yu S; Li J; Siglienti I; Chen X; Kamoun M; Rostami A
    J Immunol; 2003 Feb; 170(4):2153-60. PubMed ID: 12574388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
    Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
    J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
    J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous tolerance effectively overcomes enhanced pro-inflammatory responses and experimental autoimmune encephalomyelitis severity in the absence of IL-12 receptor signaling.
    Fitzgerald DC; Zhang GX; Yu S; Cullimore ML; Zhao Z; Rostami A
    J Neuroimmunol; 2012 Jun; 247(1-2):32-7. PubMed ID: 22522341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes in meningeal inflammation correspond to clinical exacerbations in a murine model of relapsing-remitting multiple sclerosis.
    Walker-Caulfield ME; Hatfield JK; Brown MA
    J Neuroimmunol; 2015 Jan; 278():112-22. PubMed ID: 25595260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K; Chandler P; Altmann DM
    Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
    Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
    J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation.
    Luz A; Fainstein N; Einstein O; Ben-Hur T
    Exp Neurol; 2015 Nov; 273():234-42. PubMed ID: 26342755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis.
    Sauer EL; Trifilieff E; Greer JM
    J Neuroimmunol; 2017 Jun; 307():18-26. PubMed ID: 28495132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development.
    Mimura LA; Chiuso-Minicucci F; Fraga-Silva TF; Zorzella-Pezavento SF; França TG; Ishikawa LL; Penitenti M; Ikoma MR; Sartori A
    Neuroscience; 2016 Mar; 317():130-40. PubMed ID: 26762804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of exercise in a relapsing-remitting model of experimental autoimmune encephalomyelitis.
    Klaren RE; Stasula U; Steelman AJ; Hernandez J; Pence BD; Woods JA; Motl RW
    J Neurosci Res; 2016 Oct; 94(10):907-14. PubMed ID: 27312674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X; Qin X
    Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.